New gene variants increase risk of paediatric cancer

October 4, 2012, CORDIS
New gene variants increase risk of paediatric cancer
Credit: Shutterstock

Two new gene variants have been discovered by researchers from Italy and the United States that increase the risk of neuroblastoma, a paediatric cancer. This discovery was made using automated technology to perform genome-wide association studies (GWAS) on DNA from thousands of subjects. The study has effectively broadened our understanding of how gene changes may make a child susceptible to this early childhood cancer, as well as causing a tumour to progress.

Neuroblastoma is a long-term debilitating and life-threatening disease that is associated with poor long-term survival and affects approximately 0.18 in 10,000 people in the European Union, the equivalent of around 9,100 people. It is the most common solid tumour outside the brain in children; symptoms may include weakness, bone pain, loss of appetite and fever. In many cases it is present at birth but is diagnosed later when the cancer has spread to other parts of the body and the child begins to show symptoms of the disease.

'We discovered common variants in the HACE1 and LIN28B genes that increase the risk of developing neuroblastoma. For LIN28B, these variants also appear to contribute to the tumour's progression once it forms,' said lead author Sharon J. Diskin, Ph.D., a paediatric cancer researcher at The Children's Hospital of Philadelphia. 'HACE1 and LIN28B are both known cancer-related genes, but this is the first study to link them to neuroblastoma.'

Diskin and colleagues, including senior author John M. Maris, M.D., director of the Center for Research at Children's Hospital, published the study online in . Neuroblastoma strikes the and usually appears as a solid tumour in the chest or abdomen. It accounts for 7 % of all childhood cancers, and 10 to 15 % of all childhood cancer deaths.

The research team performed a GWAS, and compared DNA from 2,800 neuroblastoma patients with that of nearly 7,500 healthy children. They found two common gene variants associated with neuroblastoma, both in the 6q16 region of chromosome 6. One variant is within the HACE1 gene, the other in the LIN28B gene. They exert opposite effects: HACE1 functions as a suppressor gene, hindering cancer, while LIN28B is an oncogene, driving cancer development.

The study showed that low expression of HACE1 and high expression of LIN28B correlated with worse patient survival. To further investigate the gene's role, the researchers used genetic tools to decrease LIN28B's activity, and showed that this inhibited the growth of neuroblastoma cells in culture.

The new research builds on previous work and GWAS work by Children's Hospital investigators implicating other common gene variants as neuroblastoma oncogenes. As in the current study, these gene variants show a double-barreled effect, both initiating cancer and provoking its progression.

'In addition to broadening our understanding of the heritable component of neuroblastoma susceptibility, we think this research may suggest new therapies,' Diskin added. 'Our follow-up studies will focus on how we may intervene on these genes' biological pathways to develop more effective treatments.'

Currently in the EU, several medicines exist and are authorised for the treatment of neuroblastoma. Treatments for neuroblastoma include surgery, chemotherapy (medicines to treat ) and radiotherapy (treatment with radiation).

Explore further: New gene variants raise risk of neuroblastoma, influence tumor progression

More information: Diskin, S.J., et al. 'Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma', Nature Genetics, 2012. doi: 10.1038/ng.2387

Related Stories

New gene variants raise risk of neuroblastoma, influence tumor progression

September 4, 2012
Researchers have discovered two gene variants that raise the risk of the pediatric cancer neuroblastoma. Using automated technology to perform genome-wide association studies on DNA from thousands of subjects, the study broadens ...

Recommended for you

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Can mice really mirror humans when it comes to cancer?

January 18, 2018
A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.